{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:26:22Z","timestamp":1786879582711,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014630","name":"Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.revmed.2026.05.013","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T23:23:48Z","timestamp":1781220228000},"page":"362-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["French protocol for diagnosis and management (guidelines) of IgG4-related disease"],"prefix":"10.1016","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9449-3392","authenticated-orcid":false,"given":"Nicolas","family":"Schleinitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Audia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fleur","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1800-4185","authenticated-orcid":false,"given":"Lionel","family":"Galicier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0810-136X","authenticated-orcid":false,"given":"Matthieu","family":"Groh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Hachulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Neel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinciane","family":"Rebours","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3070-3842","authenticated-orcid":false,"given":"Pascal","family":"Seve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Viallard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad","family":"Zaidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Ebbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bader-Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Chartier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Cottin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Gimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Emmanuel","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lefevre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Meignin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Perlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e9gory","family":"Pugnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Puyade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Sacre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2026.05.013_bib0350","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1056\/NEJM200103083441005","article-title":"High serum IgG4 concentrations in patients with sclerosing pancreatitis","volume":"344","author":"Hamano","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2026.05.013_bib0355","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2026.05.013_bib0360","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1136\/ard-2023-223950","article-title":"Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults","volume":"82","author":"Wallace","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2026.05.013_bib0365","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41584-025-01240-x","article-title":"IgG4-related disease and other fibro-inflammatory conditions","volume":"21","author":"Peyronel","year":"2025","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0370","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s13075-015-0751-x","article-title":"Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz's disease) and for differentiating it from Sj\u00f6gren's syndrome (SS), with an emphasis on sonography","volume":"17","author":"Shimizu","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.revmed.2026.05.013_bib0375","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.revmed.2020.07.006","article-title":"[Management of orbital inflammatory disorders in internal medicine: New findings resulting from a retrospective study of 31 consecutive patients]","volume":"41","author":"La Rosa","year":"2020","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2026.05.013_bib0380","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12886-021-02115-x","article-title":"IgG4-related disease in patients with idiopathic orbital inflammation","volume":"21","author":"Aryasit","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0385","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s12886-021-02210-z","article-title":"Ophthalmic involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 573 patients","volume":"21","author":"Gan","year":"2021","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0390","doi-asserted-by":"crossref","first-page":"e648","DOI":"10.1111\/aos.13968","article-title":"IgG4-related disease in patients with idiopathic orbital inflammation syndrome: data from the French SIOI prospective cohort","volume":"97","author":"Abad","year":"2019","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.revmed.2026.05.013_bib0395","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41433-020-1083-x","article-title":"Clinical features and outcomes of IgG4-related idiopathic orbital inflammatory disease: from a large southern China-based cohort","volume":"35","author":"Chen","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.revmed.2026.05.013_bib0400","doi-asserted-by":"crossref","first-page":"e6205","DOI":"10.1097\/MD.0000000000006205","article-title":"Ophthalmic manifestations in IgG4-related disease: Clinical presentation and response to treatment in a French case-series","volume":"96","author":"Ebbo","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2026.05.013_bib0405","first-page":"371","article-title":"No specific imaging pattern can help differentiate IgG4-related disease from idiopathic retroperitoneal fibrosis: 18 histologically proven cases","volume":"36","author":"Forestier","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0410","doi-asserted-by":"crossref","first-page":"210078","DOI":"10.1183\/16000617.0078-2021","article-title":"Thoracic involvement and imaging patterns in IgG4-related disease","volume":"30","author":"Muller","year":"2021","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.revmed.2026.05.013_bib0415","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/resp.14422","article-title":"Thoracic manifestations of IgG4-related disease","volume":"28","author":"Muller","year":"2023","journal-title":"Respirology"},{"key":"10.1016\/j.revmed.2026.05.013_bib0420","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2018-214603","article-title":"Clinical phenotypes of IgG4-related disease: an analysis of two international cross-sectional cohorts","volume":"78","author":"Wallace","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2026.05.013_bib0425","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3324\/haematol.2018.205526","article-title":"IgG4-related disease: what a hematologist needs to know","volume":"104","author":"Chen","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.revmed.2026.05.013_bib0430","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rmed.2016.01.014","article-title":"What are the characteristics of asthma patients with elevated serum IgG4 levels?","volume":"112","author":"Flament","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.revmed.2026.05.013_bib0435","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/ard.2011.155382","article-title":"IgG4 immune response in Churg-Strauss syndrome","volume":"71","author":"Vaglio","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2026.05.013_bib0440","doi-asserted-by":"crossref","first-page":"e0124233","DOI":"10.1371\/journal.pone.0124233","article-title":"Detection of serum IgG4 levels in patients with IgG4-related disease and other disorders","volume":"10","author":"Su","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2026.05.013_bib0445","first-page":"408","article-title":"The positive predictive value of a very high serum IgG4 concentration for the diagnosis of IgG4-related disease","volume":"50","author":"Baker","year":"2023","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0450","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","article-title":"The diagnostic utility of serum IgG4 concentrations in IgG4-related disease","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2026.05.013_bib0455","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1136\/ard-2024-225846","article-title":"Multiorgan involvement and circulating IgG1 predict hypocomplementaemia in IgG4-related disease","volume":"83","author":"Katz","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2026.05.013_bib0460","doi-asserted-by":"crossref","first-page":"102889","DOI":"10.1016\/j.autrev.2021.102889","article-title":"IgG4-related disease and hypereosinophilic syndrome: Overlapping phenotypes","volume":"20","author":"Moussiegt","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2026.05.013_bib0465","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0470","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for IgG4-Related Disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0475","doi-asserted-by":"crossref","first-page":"602809","DOI":"10.1155\/2012\/602809","article-title":"Pathologies Associated with Serum IgG4 Elevation","volume":"2012","author":"Ebbo","year":"2012","journal-title":"Int J Rheumatol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0480","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.revmed.2026.05.013_bib0485","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1093\/mr\/roae096","article-title":"The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis","volume":"35","author":"Kanda","year":"2025","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0490","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3109\/00016489.2016.1154605","article-title":"Clinicopathological analysis of salivary gland tissue from patients with IgG4-related disease","volume":"136","author":"Takano","year":"2016","journal-title":"Acta Otolaryngol (Stockh)"},{"key":"10.1016\/j.revmed.2026.05.013_bib0495","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3109\/14397595.2016.1148225","article-title":"The diagnostic utility of labial salivary gland biopsy in IgG4-related disease","volume":"26","author":"Moriyama","year":"2016","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0500","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/jcp.2010.085613","article-title":"Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders","volume":"64","author":"Strehl","year":"2011","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0505","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10067-016-3472-x","article-title":"Characteristics of primary Sj\u00f6gren's syndrome patients with IgG4 positive plasma cells infiltration in the labial salivary glands","volume":"36","author":"Liu","year":"2017","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0510","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2215\/CJN.0000000000000193","article-title":"Clinical and prognostic factors in patients with IgG4-related kidney disease","volume":"18","author":"Chaba","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0515","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.autrev.2017.07.020","article-title":"Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: A new overlap syndrome","volume":"16","author":"Danlos","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2026.05.013_bib0520","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.ekir.2024.05.011","article-title":"Clinicopathologic features of IgG4-related kidney disease","volume":"9","author":"Buglioni","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.revmed.2026.05.013_bib0525","doi-asserted-by":"crossref","first-page":"103035","DOI":"10.1016\/j.autrev.2022.103035","article-title":"A descriptive study of IgG4-related disease in children and young adults","volume":"21","author":"de Sainte Marie","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.revmed.2026.05.013_bib0530","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1093\/rheumatology\/keae497","article-title":"A rare disease with many faces: a multicentre registry of IgG4-related disease in children","volume":"64","author":"Kaya Akca","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2026.05.013_bib0535","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/art.39132","article-title":"International consensus guidance statement on the management and treatment of IgG4-related disease","volume":"67","author":"Khosroshahi","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"Suppl. 134","key":"10.1016\/j.revmed.2026.05.013_bib0540","doi-asserted-by":"crossref","first-page":"71","DOI":"10.55563\/clinexprheumatol\/qq9qup","article-title":"Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners","volume":"40","author":"Iaccarino","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0545","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/acr.22058","article-title":"Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography\/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study","volume":"66","author":"Ebbo","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.revmed.2026.05.013_bib0550","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/14397595.2020.1859710","article-title":"The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD","volume":"31","author":"Umehara","year":"2021","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0555","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10157-011-0521-2","article-title":"Proposal for diagnostic criteria for IgG4-related kidney disease","volume":"15","author":"Kawano","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0560","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/jhbp.913","article-title":"Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012)","volume":"28","author":"Nakazawa","year":"2021","journal-title":"J Hepato-Biliary-Pancreat Sci"},{"key":"10.1016\/j.revmed.2026.05.013_bib0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10384-014-0352-2","article-title":"Diagnostic criteria for IgG4-related ophthalmic disease","volume":"59","author":"Goto","year":"2015","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0570","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3400\/avd.oa.19-00085","article-title":"Clinical and pathological characteristics of IgG4-related periaortitis\/periarteritis and retroperitoneal fibrosis diagnosed based on experts\u2019 diagnosis","volume":"12","author":"Mizushima","year":"2019","journal-title":"Ann Vasc Dis"},{"key":"10.1016\/j.revmed.2026.05.013_bib0575","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1210\/jc.2010-2970","article-title":"IgG4-related hypophysitis: a new addition to the hypophysitis spectrum","volume":"96","author":"Leporati","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.revmed.2026.05.013_bib0580","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.resinv.2015.09.002","article-title":"Proposed diagnostic criteria for IgG4-related respiratory disease","volume":"54","author":"Matsui","year":"2016","journal-title":"Respir Investig"},{"key":"10.1016\/j.revmed.2026.05.013_bib0585","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1080\/14397595.2016.1259602","article-title":"A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease","volume":"27","author":"Masaki","year":"2017","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0590","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/1756-185X.13088","article-title":"Efficacy between high and medium doses of glucocorticoid therapy in remission induction of IgG4-related diseases: a preliminary randomized controlled trial","volume":"20","author":"Wu","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.revmed.2026.05.013_bib0595","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1136\/annrheumdis-2014-206605","article-title":"Rituximab for IgG4-related disease: a prospective, open-label trial","volume":"74","author":"Carruthers","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2026.05.013_bib0600","doi-asserted-by":"crossref","first-page":"e0183844","DOI":"10.1371\/journal.pone.0183844","article-title":"Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients","volume":"12","author":"Ebbo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.revmed.2026.05.013_bib0605","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/rheumatology\/kev438","article-title":"Predictors of disease relapse in IgG4-related disease following rituximab","volume":"55","author":"Wallace","year":"2016","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2026.05.013_bib0610","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejim.2020.12.006","article-title":"Efficacy and safety of rituximab biosimilar (CT-P10) in IgG4-related disease: an observational prospective open-label cohort study","volume":"84","author":"Della-Torre","year":"2021","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.revmed.2026.05.013_bib0615","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1056\/NEJMoa2409712","article-title":"Inebilizumab for treatment of IgG4-related disease","volume":"392","author":"Stone","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2026.05.013_bib0620","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1093\/rheumatology\/kez380","article-title":"Glucocorticoids and steroid sparing medications monotherapies or in combination for IgG4-RD: a systematic review and network meta-analysis","volume":"59","author":"Omar","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2026.05.013_bib0625","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/rheumatology\/key227","article-title":"Efficacy and safety of low dose Mycophenolate mofetil treatment for immunoglobulin G4-related disease: a randomized clinical trial","volume":"58","author":"Yunyun","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2026.05.013_bib0630","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/gutjnl-2012-303617","article-title":"Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis","volume":"62","author":"Hart","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.revmed.2026.05.013_bib0635","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/S0140-6736(09)61302-7","article-title":"Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study","volume":"374","author":"Beaugerie","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2026.05.013_bib0640","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.semarthrit.2020.01.010","article-title":"Additive effect of leflunomide and glucocorticoids compared with glucocorticoids monotherapy in preventing relapse of IgG4-related disease: A randomized clinical trial","volume":"50","author":"Wang","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2026.05.013_bib0645","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1038\/s41598-017-06520-5","article-title":"Efficacy of Cyclophosphamide treatment for immunoglobulin G4-related disease with addition of glucocorticoids","volume":"7","author":"Yunyun","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.revmed.2026.05.013_bib0650","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/annrheumdis-2015-208916","article-title":"Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force","volume":"75","author":"Strehl","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2026.05.013_bib0655","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/gutjnl-2016-312049","article-title":"Randomised controlled trial of long-term maintenance corticosteroid therapy in patients with autoimmune pancreatitis","volume":"66","author":"Masamune","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.revmed.2026.05.013_bib0660","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1093\/rheumatology\/keae248","article-title":"B cell depletion after treatment with rituximab predicts relapse of IgG4-related disease","volume":"64","author":"Lanzillotta","year":"2025","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2026.05.013_bib0665","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.cgh.2018.02.049","article-title":"Rituximab maintenance therapy reduces rate of relapse of pancreaticobiliary immunoglobulin G4-related disease","volume":"16","author":"Majumder","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.revmed.2026.05.013_bib0670","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejim.2019.12.029","volume":"74","author":"Campochiaro","year":"2020","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.revmed.2026.05.013_bib0675","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1093\/rheumatology\/kev244","article-title":"Methotrexate for maintenance of remission in IgG4-related disease","volume":"54","author":"Della-Torre","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.revmed.2026.05.013_bib0680","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/2050640620934911","article-title":"European Guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations","volume":"8","author":"L\u00f6hr","year":"2020","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.revmed.2026.05.013_bib0685","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/ard-2023-224487","article-title":"Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial","volume":"83","author":"Peng","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2026.05.013_bib0690","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.revmed.2021.02.003","article-title":"[Transition from pediatric to adult care: Recommendations of the French network for autoimmune and autoinflammatory diseases (FAI2R)]","volume":"42","author":"Georgin-Lavialle","year":"2021","journal-title":"Rev Med Interne"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886632600620X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S024886632600620X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T10:57:25Z","timestamp":1786877845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S024886632600620X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S024886632600620X"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2026.05.013","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"French protocol for diagnosis and management (guidelines) of IgG4-related disease","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2026.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI).","name":"copyright","label":"Copyright"}]}}